Insurers know it’s profitable to discourage patient claims

As Republicans work to repeal Obamacare, they say they want to safeguard coverage for people with pre-existing conditions. But they have yet to explain how they’ll accomplish this without also keeping the mandate that everyone buy insurance.

What isn’t being discussed is the obstacle course insurance companies and middlemen create for policyholders trying to get claims approved, often for chronic conditions. Industry bean counters have the power to reject drugs or treatments recommended by doctors.

“It’s a moneymaking tactic,” said Carmen Balber, director of Consumer Watchdog. “The companies know that when they deny claims, most people will just give up.”

Not Bill Waxman.

The 66-year-old has had repeated encounters with Anthem Blue Cross and Navitus Health Solutions, which handles his family’s prescription-drug coverage.

His 24-year-old daughter, Alison, grapples with multiple autoimmune disorders that cause chronic pain, migraines, extreme dizziness and debilitating fatigue.

There’s no cure, so he and his wife are resigned to holding jobs for as long as possible to maintain coverage. Still, Waxman estimates his out-of-pocket medical costs last year ran about $14,000.

A recent run-in involved treatment for his daughter’s postural orthostatic tachycardia syndrome, aka POTS, which keeps blood from getting to the brain when standing. According to WebMD, the dizziness, fainting and fatigue that characterize POTS “may make it hard to keep up with daily living.”

A cardiologist prescribed a heart medicine called Corlanor, which is not intended for POTS but has been shown to lower the heart rate and help a patient find equilibrium. Waxman said they tried samples of the drug and saw “immediate improvement.”

But when he tried to fill a prescription, the claim was denied by Navitus, which deemed Corlanor medically unwarranted for POTS.

Pharmacy benefit managers such as Navitus negotiate with drugmakers for the best prices. If a drug isn’t on its preferred formulary, it may not be covered by insurance. Sixty tablets of Corlanor can cost more than $400.

Waxman arranged for a “peer to peer” conversation between his daughter’s cardiologist and a Navitus health professional. Again, the claim was denied. So he appealed directly to the head of Navitus, Terry Seligman — and, lo and behold, Navitus approved a year of Corlanor. A Navitus spokeswoman declined to comment.

Last summer, Waxman said, Anthem approved a monthly IV drip to boost his daughter’s immune system. Then in September it reversed course and declared the treatment wasn’t medically necessary. A four-month regimen of intravenous gamma globulin can cost as much as $25,000.

Waxman said he spent six weeks challenging the decision. And he again prevailed.

Darrel Ng, an Anthem spokesman, attributed the situation to “miscommunication.” Waxman only knows that he’s had to fight repeatedly for his daughter’s health care.

“I’m not asking for a rhinoplasty for my daughter,” he said. “I’m asking for things that will improve her quality of life.”

His advice to others: Never take no for an answer, especially with the first denial. Make your case, stick to your guns and work your way through the appeal process.

“You have to do all the investigating yourself. You have to become conversant in medicine. You have to find the right people to contact,” Waxman said.

Balber at Consumer Watchdog said the insuers’roadblocks are intentional. “Their main tactic is to deny everything and hope the consumer won’t put up a fight,” she said.

This is the health care system we’re stuck with. So be like Waxman and stand up for what’s right.

— Los Angeles Times

Talk to us

More in Herald Business Journal

A man walks by Pfizer headquarters, Friday, Feb. 5, 2021, in New York. Pfizer will spend about $43 billion to buy Seagen and broaden its reach into cancer treatments, the pharmaceutical giant said Monday, March 13, 2023. (AP Photo / Mark Lennihan, File)
Pharmaceutical giant Pfizer to acquire Bothell-based Seagen

Pfizer announced Monday it plans to acquire Seagen in an all-cash deal for $43 billion.

Lacie Marsh-Carroll stirs wax before pouring candles in her garage at her home on March 17, 2018 in Lake Stevens. (Kevin Clark / The Daily Herald)
Women business owners in Snohomish, Island counties make their mark

In honor of Women’s History Month, we spotlight three local business owners.

Edmonds International Women’s Day takes place Saturday

The Edmonds gathering celebrates women and diversity with this year’s theme, “EmbraceEquity.”

Owner and CEO Lacie Carroll holds a “Warr;or” candle at the Malicious Women Candle Co workspace in Snohomish, Washington on Wednesday, Feb. 15, 2023. The business is women run and owned. (Annie Barker / The Herald)
Malicious Women Co: She turned Crock-Pot candles into a sassy venture

Lacie Marsh-Carroll is rekindling her Snohomish candle company with new designs and products.

Kelly Matthews, 36, left, Tonka, 6, center, and Nichole Matthews, 36, pose for a photo in their home in Lynnwood, Washington on Thursday, Feb. 2, 2023.  The twin sisters work as freelance comic book artists and illustrators. (Annie Barker / The Herald)
Drawing interest: Twin sisters never gave up on making their mark

Lynnwood sisters, Kelly and Nichole Matthews, got their big break a decade ago and now draw comics full time.

Willow Mietus, 50, poses for a photo at her home in Coupeville, Washington on Wednesday, Feb. 1, 2023. Mietus bought a former Frito-Lay truck to sell her dyed yarn out of. She calls it "The Wool Wagon." (Annie Barker / The Herald)
The Wool Wagon to hit the streets of Whidbey Island

A self-described “professional yarn temptress” from Coupeville is setting up shop in a modified truck.

IonQ will open a new quantum computing manufacturing and research center at 3755 Monte Villa Parkway in Bothell. (Photo courtesy of IonQ)
Quantum computing firm IonQ to open Bothell R&D center

IonQ says quantum computing systems are key to addressing climate change, energy and transportation.

Nathanael Engen, founder of Black Forest Mushrooms, sits in the lobby of Think Tank Cowork with his 9-year-old dog, Bruce Wayne, on Friday, Jan. 27, 2023, in downtown Everett, Washington. (Ryan Berry / The Herald)
Growing green mushrooms in downtown Everett

The founder of Black Forest Mushrooms plans to grow gourmet mushrooms locally, reducing their carbon footprint.

Barb Lamoureux, 78, poses for a photo at her office at 1904 Wetmore Ave in Everett, Washington on Monday, Jan. 23, 2023. Lamoureux, who founded Lamoureux Real Estate in 2004, is retiring after 33 years. (Annie Barker / The Herald)
Barb Lamoureux, ‘North Everett’s Real Estate Agent’ retires

A longtime supporter of Housing Hope, Lamoureux helped launch the Windermere Foundation Golf Tournament.

AGC Biologics in Bothell to produce new diabetes treatment

The contract drug manufacturer paired with drug developer Provention Bio to bring the new therapy to market.

The Walmart Store on 11400 Highway 99 on March 21, 2023 in in Everett, Washington. The retail giant will close the store on April 21, 2023. (Janice Podsada / The Herald)
Walmart announces Everett store on Highway 99 will close on April 21

The Arkansas-based retail giant said the 20-year-old Walmart location was “underperforming financially.”

Everett Memorial Stadium and Funko Field on Wednesday, Sept. 2, 2020 in Everett, Washington. (Olivia Vanni / The Herald)
Drive to build new AquaSox ballpark gets $7.4M boost from state

The proposed Senate capital budget contains critical seed money for the city-led project likely to get matched by the House.